mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.056 |
0.3 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |